🔎 Trials Near Me

Akèy › Timò sèvo ak mèvèl epinye

Etid klinik pou Timò sèvo ak mèvèl epinye ap rekrite nan Etazini

43 etid pou Timò sèvo ak mèvèl epinye ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Somatic Mosaicism in Twins Discordant for Childhood Cancer

Ap rekriteEtid obsèvasyon
Jiska laj 18 · Tout sèks · Mizajou Oct 1, 2026 · NCT06054295

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT04977375

PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07827001

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

Ap rekriteFaz 1
Laj 5 a 18 · Tout sèks · Mizajou Sep 15, 2026 · NCT06357377

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04988009

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Ap rekriteFaz 2
Laj 10 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03270059

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07098806

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05386108

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388

Brain Slice Explants to Predict Drug Response in Brain Tumors

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 4, 2026 · NCT05978557

A Study of Mirdametinib in People With Central Nervous System Tumors

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07539441

B7-H3.CD28Z.CART in CNS Neoplasms

Ap rekriteFaz 1
Laj 2 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT07390539

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study of PHST001 in Advanced Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06840886

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT03922555

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT02530658

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Ap rekriteFaz 1/2
Laj 4 a 39 · Tout sèks · Mizajou Jul 20, 2026 · NCT05278208

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT00991094

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Ap rekriteFaz 1
Laj 2 a 21 · Tout sèks · Mizajou Jun 11, 2026 · NCT04732065

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.